• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Oxford Textbook of Interventional Cardiology

Oxford Textbook of Interventional Cardiology

9780198754152
1 131,00 zł
1 017,90 zł Zniżka 113,10 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 017,90 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Cardiac catheterization and coronary angiography remain key tools in the management of patients with coronary heart disease. Although this is the most frequently used method of coronary revascularization, general training in cardiology rarely offers more than the opportunity to assist a more senior operator to perform angioplasty procedures. This textbook, covering key procedures and fully revised and updated to include the latest trials, technology, and new techniques, is essential reading. The Oxford Textbook of Interventional Cardiology, 2nd edition spans the whole spectrum of interventional cardiology procedures, including a novel section on the future of interventional cardiology, and multiple new chapters covering special devices in percutaneous coronary intervention. Written by an expert team of internationalauthors, this book offers guidance on all aspects of interventional cardiology according the European curriculum, and covers the evidence-based guidelines for a comprehensive view of the field.
Szczegóły produktu
OUP Oxford
88167
9780198754152
9780198754152

Opis

Rok wydania
2018
Numer wydania
2
Oprawa
twarda
Liczba stron
784
Wymiary (mm)
219 x 276
Waga (g)
2158
  • Background and basics; The epidemiology and pathophysiology of coronary artery disease; The history of interventional cardiology; Risk assessment and analysis of outcomes; Vascular access:: femoral versus radial; Radiation and percutaneous coronary intervention; The golden rules of percutaneous coronary intervention; Routine management after percutaneous coronary intervention; Trial design and interpretation:: statistics in PCI; Percutaneous coronary intervention-related imaging; Angiography:: indications and limitations; Coronary physiology in clinical practice; The role of intravascular ultrasound in percutaneous coronary intervention; Optical Coherence Tomography in Percutaneous Coronary Intervention; Coronary computed tomography for the interventionalist; Cardiovascular magnetic resonance; Percutaneous coronary intervention by clinical syndrome; Stable coronary artery disease:: medical therapy versus percutaneous coronary intervention versus surgery; Percutaneous coronary intervention in non-ST elevation acute coronary syndrome; Primary percutaneous coronary intervention for ST elevation myocardial infarction; Percutaneous coronary intervention in patients with impaired left ventricular function; Percutaneous coronary intervention by lesion and patient subsets; Coronary bifurcation stenting:: state of the art; Percutaneous coronary intervention for unprotected and protected left main stem disease; Chronic total occlusions; Revascularisation in patients with diabetes mellitus; Out of Hospital Arrest:: Role of PCI; Adjunctive drug therapies in percutaneous coronary intervention; Current status of oralantiplatelet therapies; Current status of GP IIb/IIIa inhibitors; The role of bivalirudin in percutaneous coronary intervention; Optimal medical therapy in percutaneous coronary intervention patients:: statins and ACE inhibitors as disease-modifying agents; New Oral Anti-Coagulants (NOACs) and other Adjunctive Therapies; Complications of percutaneous coronary intervention; Contrast-induced acute kidney injury; In-stent restenosis in the drug-eluting stent era; Stent thrombosis; Stent loss and retrieval; Coronary artery perforation; Special devices in percutaneous coronary intervention; Rotational atherectomy; Laser; Saphenous Vein Graft PCI, Distal Protection and no-reflow; Bioresorbable Vascular Scaffolds; Access Sites and the TAVI Procedure; Selection of TAVI Prostheses; Co-existent Coronary Artery Disease in Patients Undergoing TAVI:: When and When Not to Treat; Transcatheter Mitral Valve Repair; Transcatheter Mitral Valve Replacement; Other Non-coronary percutaneous interventions; Percutaneous device closure of atrial septal defect and patent foramen ovale; Mitral balloon valvuloplasty; Alcohol septal ablation for obstructive hypertrophic cardiomyopathy; Carotid artery stenting; Left Atrial Appendage Occlusion; The Future; Novel Therapies for Hypertension; Robotic PCI; Stem Cell Therapy and Delivery;
Komentarze (0)